[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201808927D0 - Materials and methods for monitoring the development of resistance of cancers to treatment - Google Patents

Materials and methods for monitoring the development of resistance of cancers to treatment

Info

Publication number
GB201808927D0
GB201808927D0 GBGB1808927.6A GB201808927A GB201808927D0 GB 201808927 D0 GB201808927 D0 GB 201808927D0 GB 201808927 A GB201808927 A GB 201808927A GB 201808927 D0 GB201808927 D0 GB 201808927D0
Authority
GB
United Kingdom
Prior art keywords
cancers
monitoring
development
resistance
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808927.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Priority to GBGB1808927.6A priority Critical patent/GB201808927D0/en
Publication of GB201808927D0 publication Critical patent/GB201808927D0/en
Priority to PCT/EP2019/064231 priority patent/WO2019229259A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1808927.6A 2018-05-31 2018-05-31 Materials and methods for monitoring the development of resistance of cancers to treatment Ceased GB201808927D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1808927.6A GB201808927D0 (en) 2018-05-31 2018-05-31 Materials and methods for monitoring the development of resistance of cancers to treatment
PCT/EP2019/064231 WO2019229259A1 (en) 2018-05-31 2019-05-31 Materials and methods for monitoring the development of resistance of cancers to treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808927.6A GB201808927D0 (en) 2018-05-31 2018-05-31 Materials and methods for monitoring the development of resistance of cancers to treatment

Publications (1)

Publication Number Publication Date
GB201808927D0 true GB201808927D0 (en) 2018-07-18

Family

ID=62872782

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808927.6A Ceased GB201808927D0 (en) 2018-05-31 2018-05-31 Materials and methods for monitoring the development of resistance of cancers to treatment

Country Status (2)

Country Link
GB (1) GB201808927D0 (en)
WO (1) WO2019229259A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102263983B1 (en) * 2020-02-12 2021-06-11 씨비에스바이오사이언스 주식회사 Analytical method for increasing susceptibility of sorafenib treatment in hepatocellular carcinoma
CN112941180A (en) * 2021-02-25 2021-06-11 浙江大学医学院附属妇产科医院 Group of lung cancer DNA methylation molecular markers and application thereof in preparation of lung cancer early diagnosis kit
CN115125296B (en) * 2022-06-07 2023-04-07 北京大学第一医院 Application of regorafenib drug sensitive marker and related reagent thereof
WO2024084458A1 (en) * 2022-10-20 2024-04-25 Cbci Society For Medical Education (Cbci) Methods for assessing compliance or non-compliance of treatment and chronic myeloid leukemia progression or non-progression

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DK0617706T3 (en) 1991-11-25 2001-11-12 Enzon Inc Multivalent antigen-binding proteins
AU690528B2 (en) 1992-12-04 1998-04-30 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
DK0979281T3 (en) 1997-05-02 2005-11-21 Genentech Inc Process for the preparation of multispecific antibodies with heteromultimers and common components
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
EP1235842A4 (en) 1999-10-15 2003-04-23 Univ Massachusetts Rna interference pathway genes as tools for targeted genetic interference
JP2009515526A (en) * 2005-11-12 2009-04-16 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッド Gene expression profiles and methods of use
EP2954068B8 (en) * 2013-02-05 2018-10-31 Pierian Holdings, Inc. Drug selection for non-small cell lung cancer therapy

Also Published As

Publication number Publication date
WO2019229259A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
IL292094A (en) Neoantigens and methods of their use
HK1257955A1 (en) Materials and methods for treatment of titin-based myopathies and other titinopaties
HRP20210526T8 (en) Oxysterols and methods of use thereof
IL258397A (en) Anti-age antibodies and methods of use thereof
IL266093A (en) Oxysterols and methods of use thereof
IL289976A (en) Oxysterols and methods of use thereof
IL266092A (en) Oxysterols and methods of use thereof
HK1255500A1 (en) Oxysterols and methods of use thereof
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancers and other medical conditions
ZA201905677B (en) Glycan-interacting compounds and methods of use
IL272821A (en) Tim-3 antagonists for the treatment and diagnosis of cancers
PT3481846T (en) Oxysterols and methods of use thereof
PT3436022T (en) Oxysterols and methods of use thereof
GB201808927D0 (en) Materials and methods for monitoring the development of resistance of cancers to treatment
IL250507A0 (en) Anti-ck8 antibodies for use in the treatment of cancers
PL3722291T3 (en) Indolinone compounds and their use in the treatment of fibrotic diseases
IL272810A (en) Methods of diagnosing and treating lung cancer
GB201417281D0 (en) Methods and devices relating to the detection of oral cancer biomarkers
GB201421511D0 (en) Methods of screening and treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)